Consultation-Liaison Case Conference: Stimulant-Induced Tardive Dyskinesia

A, a 35-year-old nonbinary patient with a complex psychiatric history, including major depressive disorder with psychotic features, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD), who developed tardive dyskinesia (TD) following stimulant (amphetamine/dextroamphetamine) initiation, which improved significantly after discontinuing the stimulant and switching to quetiapine. The case highlights the challenges of managing TD in patients with overlapping…

via https://pubmed.ncbi.nlm.nih.gov/41349717/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20251217010905&v=2.18.0.post22+67771e2